| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
4,694 |
3,673 |
$356K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
4,694 |
3,549 |
$225K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
3,767 |
2,812 |
$133K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
1,591 |
1,192 |
$108K |
| 96127 |
|
6,355 |
4,573 |
$106K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
1,542 |
1,049 |
$93K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
1,235 |
1,007 |
$86K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
4,660 |
3,439 |
$73K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
3,282 |
2,471 |
$61K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
770 |
594 |
$57K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
2,270 |
1,699 |
$53K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
1,918 |
1,032 |
$39K |
| 87428 |
|
595 |
413 |
$38K |
| 96160 |
|
1,757 |
1,374 |
$32K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
1,182 |
932 |
$30K |
| Q3014 |
Telehealth originating site facility fee |
492 |
248 |
$12K |
| 99173 |
|
1,604 |
1,271 |
$12K |
| 94760 |
|
2,915 |
2,397 |
$12K |
| 83655 |
|
707 |
490 |
$8K |
| 99000 |
|
428 |
346 |
$8K |
| 90686 |
|
423 |
346 |
$7K |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
410 |
337 |
$6K |
| 90651 |
|
289 |
244 |
$5K |
| 0072A |
|
119 |
118 |
$5K |
| 0071A |
|
115 |
109 |
$5K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
379 |
319 |
$4K |
| 85018 |
|
1,518 |
1,129 |
$4K |
| 90633 |
|
195 |
154 |
$3K |
| 90656 |
|
193 |
186 |
$3K |
| 90670 |
|
180 |
151 |
$3K |
| 36416 |
|
728 |
575 |
$3K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
69 |
44 |
$3K |
| 99072 |
|
585 |
438 |
$3K |
| 90677 |
|
137 |
86 |
$2K |
| 90619 |
|
85 |
69 |
$1K |
| 90680 |
|
69 |
39 |
$1K |
| 90698 |
|
66 |
57 |
$1K |
| 91321 |
|
35 |
33 |
$665.52 |
| G2012 |
Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m service provided within the previous 7 days nor leading to an e/m service or procedure within the next 24 hours or soonest available appointment; 5-10 minutes of medical discussion |
30 |
28 |
$382.51 |
| 90697 |
|
19 |
14 |
$317.49 |
| 90621 |
|
19 |
17 |
$317.49 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
16 |
14 |
$232.00 |
| 1036F |
|
776 |
462 |
$0.00 |
| 3008F |
|
190 |
163 |
$0.00 |
| 1220F |
|
81 |
45 |
$0.00 |
| 3351F |
|
66 |
33 |
$0.00 |
| 96161 |
|
12 |
12 |
$0.00 |
| 3210F |
|
2,026 |
1,257 |
$0.00 |
| 4274F |
|
593 |
307 |
$0.00 |
| 1003F |
|
2,670 |
1,676 |
$0.00 |
| 1033F |
|
30 |
13 |
$0.00 |